The artificial intelligence sector has been on the agenda lately with artificial intelligence tools that you can “write” directly with those who convert text to text. Among them are the most popular Open AI However, AI tools like DALL-E and ChatGPT released by OpenAI will be much more in the near future. in different sectors Also it looks like it will show up.

Founder of OpenAI Sam AltmanIt turned out that he was also interested in “immortality”. The famous businessman invested 180 million dollars in a company called Retro Biosciences. Retro Biosciences, which appears as a biotechnology company, is the life expectancy of a healthy person. for a 10-year extension some work in progress.

Sam Altman has cared about immortality studies in the past

In the statements about the incident put forth by the MIT Technology Review, Sam Altman is actually years ago It is said that he was interested in immortality and even conducted a study called “young blood” and turned this study into an article. As part of the young blood test, the skins of young mice were attached to old mice, resulting in brain and muscle tissue from old mice. there is rejuvenation had been discovered.

That’s not the only interesting thing about Sam Altman’s investment. entrepreneur for years Joe Betts-LaCroix Collaborated with a scientist named So what does this name do today? Joe Betts-LaCroix is ​​the number one name in Retro Biosciences. Betts-LaCroix, during his statements on the subject, stated that Altman’s work was not limited to this and blood plasma from aged mice was obtained in 2020. of dilution He also stated that they have researched whether it has a rejuvenating effect.